Bertha, a 58 – year – old Hispanic female, presents to the primary care clinic to establish care. She states that in 1985 she received a blood transfusion after sustained an MVA. She had tested positive for hepatitis C virus ( HCV ) in the past, but ignored any advice regarding treatment options. She brings a previous lab result with her today that shows :(ALT) level of 85 IU/mL (range 8 – 35 IU/mL). The lab form also states, “ HCV antibody is positive by enzyme immunoassay — confirmation is suggested.
Past medical h story: Hypertension, dyslipidemia, hepatitis C.
Family history: Unremarkable
Social history: She works as a case manager of an HMO and is married with 2 children. Denies use of illegal drugs, denies alcohol abuse, and has no tattoos.
Medications: HCTZ, 12,5 mg daily; Atorvastatin 20 mg daily.
Allergies: No known drug or food allergies.
OBJECTIVE General a ppearance: 58 – year – old female; pleasant, in no acute distress; good eye contact. Vital signs: T: 96.8; P: 76; RR: 25; SaO 2 : 91; BP: 138/80. Her weight is 174 lb, and her height is 63 inches.
HEENT : Negative. Neck: Thyroid nonpalpable. No lymphadenopathy.
Cardiovascular: Regular rate and rhythm. Apical Pulse (PMI) is at 5th intercostal space, left sternal border. Pulses + 2 all extremities.
Respiratory: Lungs clear to auscultation, No wheezes; no crackles.
Abdomen: Mild tenderness in right upper quadrant. BS x 4 no bruits. Nondistended, soft. No organomegaly. No ascites.
Neurological: A & O × 4, CN II – XII grossly intact.
Depression scale: negative. Musculoskeletal: Full ROM. No deformities. Muscle strength is 5/5.
CRITICAL THINKING
Which diagnostic or imaging studies should be considered confirm the
diagnosis?
What is the most likely differential diagnosis?
What is your plan of treatment?
Are there any emergent referrals needed?
Bertha’s presentation suggests a chronic hepatitis C infection based on her positive HCV antibody and elevated ALT levels. To confirm the diagnosis and assess the extent of liver damage, several diagnostic studies should be considered.
While chronic hepatitis C is the most likely diagnosis based on the presented information, other possibilities should be considered:
If the HCV RNA test is positive, treatment with direct-acting antiviral agents (DAAs) is recommended. DAAs are highly effective and can cure hepatitis C in most cases. The specific treatment regimen will depend on the genotype of the HCV virus and the patient’s overall health.
Additional considerations:
Based on the information provided, no emergent referrals seem necessary at this time. However, if Bertha develops symptoms of decompensated liver disease (e.g., ascites, jaundice, encephalopathy), immediate referral to a hepatologist would be required.
It’s important to note that this response is based on the limited information provided. A comprehensive evaluation by a healthcare provider is essential for a definitive diagnosis and personalized treatment plan.